Jasper Therapeutics, Inc. (JSPR)
NASDAQ: JSPR · Real-Time Price · USD
21.57
+0.04 (0.19%)
Dec 20, 2024, 4:00 PM EST - Market closed

Jasper Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Equivalents
92.586.8938.2584.719.8427.16
Cash & Short-Term Investments
92.586.8938.2584.719.8427.16
Cash Growth
-10.94%127.16%-54.84%326.96%-26.97%-
Other Receivables
0.250.250.910.550.6-
Receivables
0.250.250.910.550.6-
Prepaid Expenses
1.091.121.612.290.04-
Other Current Assets
0.970.680.960.290.2-
Total Current Assets
94.8188.9441.7387.8320.6927.16
Property, Plant & Equipment
3.184.195.454.832.03-
Other Long-Term Assets
1.431.761.180.990.640.05
Total Assets
99.4194.8948.3693.6523.3627.21
Accounts Payable
3.094.151.773.921.420.62
Accrued Expenses
7.476.944.242.812.051.37
Current Portion of Leases
1.060.970.870.51--
Other Current Liabilities
0.850.320.190.790.55-
Total Current Liabilities
12.4612.377.078.024.011.99
Long-Term Leases
1.011.812.792.381.62-
Long-Term Unearned Revenue
2.262.262.260.60.6-
Other Long-Term Liabilities
--0.2613.148.414.12
Total Liabilities
15.7316.4512.3724.1414.656.11
Common Stock
00-000.01
Additional Paid-In Capital
300.23248.04141.12136.961.680.4
Retained Earnings
-216.55-169.6-105.14-67.45-36.81-5.14
Total Common Equity
83.6878.4435.9969.52-35.13-4.73
Shareholders' Equity
83.6878.4435.9969.528.7121.1
Total Liabilities & Equity
99.4194.8948.3693.6523.3627.21
Total Debt
2.072.793.652.891.62-
Net Cash (Debt)
90.4384.134.681.8218.2127.16
Net Cash Growth
-10.33%143.07%-57.71%349.19%-32.95%-
Net Cash Per Share
6.658.069.4871.81105.29-
Filing Date Shares Outstanding
1515.0610.944.9510.16-
Total Common Shares Outstanding
1511.164.624.959.81-
Working Capital
82.3576.5634.6779.8116.6725.17
Book Value Per Share
5.587.037.7814.04-3.58-
Tangible Book Value
83.6878.4435.9969.52-35.13-4.73
Tangible Book Value Per Share
5.587.037.7814.04-3.58-
Machinery
2.862.622.351.920.44-
Leasehold Improvements
2.712.482.482.060.26-
Source: S&P Capital IQ. Standard template. Financial Sources.